![Memorial Sloan Kettering Medical Oncologist Jennifer Lue](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/235729/3x2/lue-jennifer_14-1200x800.jpg?h=10d202d3)
Jennifer K. Lue, MD
Lymphoma Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- All non-Hodgkin and Hodgkin Lymphomas
- Diffuse Large B-cell Lymphoma
- Follicular Lymphoma
Request an Appointment
About Me
- Clinical Director, Lymphoma Service
I am a medical oncologist and hematologist dedicated to caring for people with lymphoma, including non-Hodgkin and Hodgkin lymphoma. As a member of MSK’s Division of Hematologic Oncology, my goal is to provide unparalleled care that is tailored to each patient’s unique situation. To do so, I collaborate with various experts at MSK, including pathologists, radiologists, radiation oncologists, and transplant specialists. We work together to ensure that our patients receive the best care possible.
Read more
I am passionate not only about caring for patients with lymphoma but also about participating in research that focuses on the development of novel therapeutics and drug combinations for the treatment of this cancer. I am particularly interested in exploring how novel therapies can be used with personalized medicine approaches to further customize patient care. Ultimately, my overarching goal is to improve clinical outcomes for patients diagnosed with lymphoma.
I understand that receiving a lymphoma diagnosis can be quite frightening and anxiety-provoking. As a result, my mission is to provide clear and concise information at every visit, and to answer any questions that a patient might have throughout our journey together. I strongly believe that clear communication is key to allaying fears associated with a lymphoma diagnosis. With this approach, I help my patients feel secure and supported throughout the various stages of diagnosis and treatment.
A lymphoma specialist is a doctor with special training in diagnosing and treating lymphoma.
My Specialties
- All non-Hodgkin and Hodgkin Lymphomas
- Diffuse Large B-cell Lymphoma
- Follicular Lymphoma
- Marginal Zone Lymphoma
- Mantle Cell Lymphoma
- Small Lymphocytic/Chronic Lymphocytic Leukemia
- Burkitt Lymphoma
- Post-Transplant Lymphoproliferative Disorder
- Peripheral T-cell Lymphoma
- Phase I Therapy
- Novel Therapeutic Agents
- Personalized Therapy
Education
- MD, New York University School of Medicine
Residencies
- Internal Medicine - New York University School of Medicine
Awards and Honors
- American Society of Hematology Abstract Achievement Award (2016)
- American Society of Clinical Oncology Young Investigator’s Award (2017)
- American Cancer Society Clinician Scientist Development Grant (2020)
Fellowships
- Hematology and Medical Oncology - Columbia University Medical Center
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Lue sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Lue
- A Phase 1 Study of BMS-986458 Alone and With Rituximab in People With Non-Hodgkin Lymphoma
- Clinical Trials Co-Investigated by Dr. Lue
- A Phase 2 Study of Nanatinostat and Valganciclovir in People With Lymphoma
- A Phase II Study Assessing Venetoclax Added to Ibrutinib and Rituximab for Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Lue’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jennifer K. Lue discloses the following relationships and financial interests:
-
ADC Therapeutics
Professional Services and Activities -
ARK Genomic Revolution ETF
Equity -
Genentech
Professional Services and Activities (Uncompensated)
-
GenMab
Professional Services and Activities -
Merck Sharp & Dohme Ireland (Human Health) Ltd
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].